Increased BMAL1 in ccRCC compared to non-tumor biopsies remains statistically significant when only adjacent samples from the same patients are included in the analysis, suggesting that elevated BMAL1 in ccRCC samples is not an artefact of tissue collection time or differential sample processing (Fig. S1B). The gene discussed is BMAL1; the disease is neoplasm.